Back to User profile » Prof. Dr. Silverio Tomao

Papers published by Prof. Dr. Silverio Tomao:


Triple-negative breast cancer: new perspectives for targeted therapies

Tomao F, Papa A, Zaccarelli E, Rossi L, Caruso D, Minozzi M, Vici P, Frati L, Tomao S

OncoTargets and Therapy 2015, 8:177-193

Published Date: 16 January 2015

Angiogenesis and antiangiogenic agents in cervical cancer

Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S

OncoTargets and Therapy 2014, 7:2237-2248

Published Date: 3 December 2014

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation

Rossi L, Veltri E, Zullo A, Zoratto F, Colonna M, Longo F, Mottolese M, Giannarelli D, Ruco L, Marchetti P, Romiti A, Barucca V, Giannini G, Bianchi L, Tomao S

OncoTargets and Therapy 2013, 6:1761-1769

Published Date: 29 November 2013

Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)

Rossi L, Vakiarou F, Zoratto F, Bianchi L, Papa A, Basso E, Verrico M, Lo Russo G, Evangelista S, Rinaldi G, Perrone-Congedi F, Spinelli GP, Stati V, Caruso D, Prete A, Tomao S

Cancer Management and Research 2013, 5:377-385

Published Date: 19 November 2013

Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

Rossi L, Tomao F, Lo Russo G, Papa A, Zoratto F, Marzano R, Basso E, Giordani E, Verrico M, Ricci F, Pasciuti G, Francini E, Tomao S

Therapeutics and Clinical Risk Management 2013, 9:457-462

Published Date: 11 November 2013

Current status of bevacizumab in advanced ovarian cancer

Tomao F, Papa A, Rossi L, Caruso D, Benedetti Panici P, Venezia M, Tomao S

OncoTargets and Therapy 2013, 6:889-899

Published Date: 22 July 2013

Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer

Zoratto F, Rossi L, Zullo A, Papa A, Zaccarelli E, Tomao L, Giordani E, Colonna M, Baiano G, Tomao S

OncoTargets and Therapy 2012, 5:199-211

Published Date: 24 September 2012

Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer

Evelina Miele, Gian Paolo Spinelli, Ermanno Miele, Federica Tomao, Silverio Tomao

International Journal of Nanomedicine 2009, 4:99-105

Published Date: 27 April 2009